Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients

por Abou Zaghla, Heba M. Adel, El Sebai, Aziza Ahmed, Ahmed, Ossama Ashraf, Ahmed, Ayat Fawzy, Saab, Azza Abdel Rahman
Publicado 2021

Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study

por Abd-Elsalam, Sherief, Esmail, Eslam Saber, Khalaf, Mai, Abdo, Ehab Fawzy, Medhat, Mohammed A., Abd El Ghafar, Mohamed Samir, Ahmed, Ossama Ashraf, Soliman, Shaimaa, Serangawy, Ghada N., Alboraie, Mohamed
Publicado 2020

Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial

por Abd-Elsalam, Sherief, Soliman, Shaimaa, Esmail, Eslam Saber, Khalaf, Mai, Mostafa, Ehab F., Medhat, Mohammed A., Ahmed, Ossama Ashraf, El Ghafar, Mohamed Samir Abd, Alboraie, Mohamed, Hassany, Sahar M.
Publicado 2020

Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village

por Ahmed, Ossama Ashraf, Safwat, Eslam, Khalifa, Mohamed Omar, Elshafie, Ahmed I., Fouad, Mohamed Hassan Ahmed, Salama, Mohamed Magdy, Naguib, Gina Gamal, Eltabbakh, Mohamed Mahmoud, Sherief, Ahmed Fouad, Abd-Elsalam, Sherief
Publicado 2018